Stryker Corporation(SYK)NASDAQ
Company Profile & Information
Company Profile
Business overview, scale, and footprint
Business Overview
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Insider Transactions
Open-market activity and option exercises
Insider Activity Summary
Insider trading activity for Stryker Corporation (SYK) over the last 3 months consists of 111 total transactions. Among these, company executives and board members conducted 111 buys (totaling 5,481,262 shares) and 0 sells (totaling 0 shares). This activity resulted in a net change of 5,481,262 shares, reflecting net buying interest with an estimated net acquisitions value of $376.22M.
111 insider transactions found. Showing 10 of 111 transactions.
| Insider Name | Relation to Company | Shares Changed | Price | Transaction Date |
|---|---|---|---|---|
| CROTTY DYLAN BRAM | Officer | 441 | $0.14 | Aug 21, 2026 |
| STRYKER RONDA E | Director | 350,000 | $117.78 | Aug 19, 2026 |
| KING DEBRA | Officer | 826 | $0.28 | Aug 18, 2026 |
| STILES SPENCER S | President | 1,607 | $N/A | Jun 1, 2026 |
| FLETCHER ROBERT S | Officer | 4,544 | $1.39 | May 28, 2026 |
| STRYKER RONDA E | Director | 310,000 | $96.79 | May 26, 2026 |
| FINK MARY KATHRYN | Officer | 8,720 | $2.47 | May 11, 2026 |
| FINK MARY KATHRYN | Officer | 21,582 | $3.63 | May 8, 2026 |
| RUGGERI RACHEL | Director | 762 | $N/A | May 6, 2026 |
| MONTAGNINO KIMBERLY ANN | Officer | 677 | $N/A | May 6, 2026 |
Explore More Analysis for SYK
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.